Service

Life sciences reimagined

KPMG and Microsoft are helping organizations to accelerate their large-scale transformation programs.

Justin Hoss

Justin Hoss

National Technology Sector Leader, Life Sciences, KPMG US

+1 312-665-3265

Digital disruption and increased consumer expectation continue to create opportunities and risks for this rapidly evolving industry.

The patient is becoming a consumer of healthcare

Patients have more influence and buying power on their health services and therapies than ever before. Product-based companies are left with no choice, they must move closer to the patient care continuum. Failure to do so will impact business performance. To rise to this new set of challenges, leaders must disrupt, change their delivery models and develop new digital experiences for their patients.

Bold decisions

From the small biotechs to the large multinational pharmaceutical companies, bold investments and courageous decisions mean that large scale transformation projects are being undertaken across the entire value chain, rather than component parts.

To successfully transform, and to narrow the consumer and patient divide, leaders need to look at, and reshape, their operating models and rethink how to best serve their patients. They need to have access to the right digital eco-system, start with Cloud first and invest in transformative technologies. They must also consider their risk, growth and innovation agendas.

KPMG and Microsoft are helping organizations to accelerate their large-scale transformation programs.

 

Proactive monitoring on Azure – powered by AI cognitive detection 


 


Some or all of the services described herein may not be permissible for KPMG audit clients and their affiliates or related entities. Any trademarks or service marks herein are the property of their respective owners.